Lower is Better for PBC Candidate Drug Safety signal for seladelpar disappeared at lower doses Oct 24, 2017
Vets with HCV Might Settle Cancer Controversy VA experience seems to rule out possible cancer-causing effect of new drugs Oct 23, 2017
'Split Livers:' Life-Saving Options for Kids Who Need Transplant? Divided-organ approach works in U.K., but may be a tough sell in U.S. Oct 22, 2017
PBC Drug Shows Benefit Beyond Standard Response Findings imply that ursodeoxycholic acid therapy should not be discontinued Oct 22, 2017
EMR Alerts Up HCV Screening in Baby Boomers But testing for hepatitis C virus still falls short of USPSTF guidelines Oct 22, 2017
Novel Tx for Hepatic Encephalopathy Works Fast Lowers ammonia level more quickly than standard care, study finds Oct 22, 2017
Liver Ca Transplant Rates Vary by Ethnicity Blacks have lower rates despite same degree of illness, study finds Oct 21, 2017
AASLD Liver Meeting Covers a Lot of Ground New science could 'potentially change the field' Oct 19, 2017
Timing of Meals Linked to Fatty Liver Distributing calories during the day could reduce NAFLD risk Nov 14, 2016
Marked Sex Difference Seen in Drug-Induced Liver Failure Brain damage, polypharmacy more common in women with ALF Nov 12, 2016
Investigative Combo Pill Effective Against HCV Infection Treating refractory HCV without ribavirin onboard. Nov 13, 2014
No Need for Cancer Watch in Cirrhotic Wilson's Disease Hepatocellular carcinoma is too infrequent to merit regular surveillance. Nov 10, 2014
Studies 'Validate' CDC HCV Testing Advice WASINGTON -- Thousands of people in the U.S. -- including an estimated 50,000 veterans -- are infected with the hepatitis C virus, and don't know it, researchers reported here. Nov 06, 2013
Supplements Blamed for Liver Toxicity WASHINGTON -- The rate of liver damage caused by dietary and herbal supplements -- especially those used for bodybuilding -- appears to be on the rise, a researcher said here. Nov 06, 2013
Babies Do OK if Mom on Tenofovir for Hepatitis B WASHINGTON -- Pregnant women being treated for hepatitis B virus infections with the nucleotide inhibitor tenofovir (Viread) appeared to avoid transmission of the pathogen to their unborn children, researchers reported here. Nov 04, 2013
